Invion Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Invion Limited with three other
companies in this sector in AUSTRALIA :
Exopharm Ltd
(2020
sales of 2.67 million Australian Dollars [US$2.03 million]
),
Imugene Limited
(4.21 million Australian Dollars [US$3.21 million]
of which 100%
was Health technologies), and
Oncosil Medical Ltd
(2.87 million Australian Dollars [US$2.19 million]
of which 100%
was Medical Treatments).
Sales Analysis.
Invion Limited reported sales of A$3.48 million (US$2.65 million)
for the
fiscal
year ending
June of 2020.
This
represents
a
decrease of 10.4%
versus 2019, when the company's sales were A$3.88 million.